Diabetes
Dr. Alexander Fleming Named to Diakine Therapeutics' Scientific Advisory Board
Published in Medical Letter on the CDC and FDA, June 3rd, 2007
Dr. Fleming is a well recognized authority in the metabolic and endocrine fields with extensive U.S. Food and Drug Administration (FDA) experience. He served 12 years as FDA Supervisory Medical Officer for diabetes and other metabolic and endocrine disorders and held assignments with World Health Organization (WHO) and the International Conference on Harmonization (ICH). He led reviews and was responsible for the regulation of the earliest biotech...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Epidemic
Book Explores History, Causes of Allergy and Asthma Epidemic - Gender Studies
SWHR Issues Report to Help FDA Critical Path Initiative Advance Sex Differences - Hypothermia
Lowering Body Temperature Could Aid Standard Stroke Treatment - West Nile Virus
UT Southwestern joins national clinical trial that seeks to uncover long-term effects of West Nile virus - AdvaMed
Advamed Commends Passage of FDA Revitalization Act - Arthritis
Can-Fite to Commence Phase II Clinical Trials to Investigate the Efficacy of CF101 in the Treatment of Psoriasis - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
